logo

For the Inventor, By the Inventor

Sunnyvale, CA, United States of America

Chee-Liang L Gu

This inventor holds 11 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1988-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chee-Liang L Gu. Retrieved from https://idiyas.com/inventor/chee-liang-l-gu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 10

Forward Citations = 260(Granted Patents)


Location History:

  • Synnyvale, CA (US) (1990)
  • Sunnyvale, CA (US) (1988 - 1993)

Company Filing History:

goldMedal11 out of 932 
 
Syntex (u.s.a.) Inc.
 patents

Years Active: 1988-1993

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5177072 - Treatment of autoimmune inflammatory, and psoriatic diseases with (1993-01-05),
2. 4992467 - Treatment of autoimmune diseases with mycophenolic acid, and derivatives (1991-02-12),
3. 4952579 - Method of treating diseases by administering morpholino-ethylester of (1990-08-28),
4. 4948793 - Treatment of autoimmune diseases with the morpholinoethyl ester of (1990-08-14),
5. 4868153 - Treatment of allograft rejection with mycophenolic acid, its (1989-09-19),
6. 4861776 - Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives (1989-08-29),
7. 4808592 - Method of treating diseases by administering morpholinoethylester of (1989-02-28),
8. 4786637 - Treatment of allograft rejection with mycophenolic acid (1988-11-22),
9. 4753935 - Morpholinoethylesters of mycophenolic acid and pharmaceutical (1988-06-28),
10. 4748173 - Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives (1988-05-31),
11. 4727069 - Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof (1988-02-23),

Title: Chee-Liang L Gu: Innovator in Immunosuppressive Treatments

Introduction

Chee-Liang L Gu is a prominent inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of immunology, particularly in the treatment of autoimmune diseases. With a total of 11 patents to his name, Gu's work has had a profound impact on medical science.

Latest Patents

Gu's latest patents focus on innovative treatments for autoimmune inflammatory and psoriatic diseases. One of his notable inventions involves the use of heterocyclic aminoalkyl esters of mycophenolic acid and their derivatives. These compounds are recognized for their potential as immunosuppressive agents, anti-inflammatory agents, anti-tumor agents, anti-viral agents, and anti-psoriatic agents. Another significant patent addresses the treatment of autoimmune diseases with mycophenolic acid and its derivatives. The pharmaceutical compositions he developed are particularly useful for treating allograft rejection, including cardiac, pancreatic, and renal allograft rejection, as well as autoimmune diabetes.

Career Highlights

Chee-Liang L Gu has built a successful career at Syntex (U.S.A.) Inc., where he has been instrumental in advancing research and development in immunology. His innovative approaches have led to breakthroughs in the treatment of various autoimmune conditions.

Collaborations

Gu has collaborated with esteemed colleagues such as William A Lee and Elsie M Eugui. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.

Conclusion

Chee-Liang L Gu's contributions to the field of immunology through his patents and collaborative efforts have positioned him as a key figure in the development of treatments for autoimmune diseases. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…